IBA (Ion Beam Applications S.A.) has signed three separate binding term sheets with Proton Partners International (PPI) to install three of its Proteus One compact proton therapy solutions in private clinics in the United Kingdom. The agreements contain significant and immediate down-payments.

Ten weeks of intensive reading intervention for children with autism spectrum disorder (ASD) strengthened loosely connected areas of their brains that comprehend reading, University of Alabama at Birmingham researchers found. At the same time, the reading comprehension of those 13 children, whose average age was 10.9 years, also improved.

Medraysintell released its updated World Market Report and Directory on Nuclear Medicine, Edition 2015, in late June, providing a description and analysis of the latest developments in nuclear medicine. The 920-page document covers 335 radiopharmaceuticals and radionuclides and 160 companies and institutions active in nuclear medicine.


Years ago in Vegas I came face-to-face with the strain of radiology.  On-site, at an imaging practice built around managed care, I sat from 9 in the morning until 7 that night observing (as unobtrusively as possible) a radiologist. At day's end he retreated to his office, dragging me with him for a recap of the day, his eyes puffy and bloodshot.



Just a few short years ago, the only options for breast imaging were 2-D mammography, but thanks to rapidly advancing technology to address accuracy concerns in reading dense breast images, today there several options, including 3-D tomosynthesis.


With radiology departments generating so much imaging data on a daily basis, and as medical imaging technology continues to advance, many existing picture archiving and communication systems (PACS) and other storage solutions simply do not have the capacity to handle multiple terabytes of data on-site. As a result, hospitals and other healthcare organizations are turning to cloud solutions. It is a buzzword that many are familiar with, but one that many still do not fully understand. 



Image-guided radiation therapy (IGRT) affords greater accuracy of dose distribution during cancer treatment, allowing the radiation oncologist to see how a tumor is responding over the course of treatment. This has traditionally been accomplished with computed tomography (CT) or X-ray scans, which requires extra radiation exposure for the patient, with relatively poor contrast in soft tissue due to uniform electron density. Since treatment is only as good as the images provided, efforts are under way to find a better modality — and magnetic resonance imaging (MRI) may hold the answer. 



Molecular imaging is a broad and dynamic field that encompasses a range of image technologies that allow physicians and researchers to noninvasively visualize biological processes at the cellular and molecular level. Currently, the vast majority of clinical applications of molecular imaging use radiolabeled compounds (radiopharmaceuticals) that are detected with gamma cameras, single-photon emission computed tomography (SPECT) or positron emission tomography (PET), depending on the type of radioactivity used. Molecular imaging techniques typically complement more anatomic-based imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI), and hybrid imaging modalities including SPECT/CT, PET/CT and more recently PET/MRI are available for clinical use. Together, multimodality molecular imaging can more accurately localize and characterize disease processes than either modality alone.


State-of-the-art imaging displays are a must for the healthcare arena, and today have an increasing capacity to offer large, high-resolution displays, color accuracy, calibrated brightness, advanced connectivity, optimized workflow and high contrast, just to name a few. A variety of vendors continue to improve the technology to better display imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), X-ray, positron emission tomography (PET), mammography and ultrasound, and to ensure screens remain DICOM (digital imaging and communications in medicine) compliant.


The U.S. Food and Drug Administration (FDA) announced its latest efforts in supporting the Bonn Call for Action on radiation protection.


Subscribe Now